(2014). Cardiac glycosides and the risk of breast cancer in women with chronic heart failure and supraventricular arrhythmia. Breast Cancer Res Treat. http://doi.org/10.1007/s10549-014-3058-8
. N. Bouganim
First name
N.
Last name
Bouganim
(2016). Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study. Epidemiology. http://doi.org/10.1097/ede.0000000000000483
. (2017). The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer. Br J Cancer. http://doi.org/10.1038/bjc.2016.375
. (2018). Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study. Bmj. http://doi.org/10.1136/bmj.k4880
. (2018). Aromatase inhibitors and the risk of colorectal cancer in postmenopausal women with breast cancer. Ann Oncol. http://doi.org/10.1093/annonc/mdx822
. (2020). Weight-lowering effects of glucagon-like peptide-1 receptor agonists and detection of breast cancer among obese women with diabetes. Epidemiology. http://doi.org/10.1097/ede.0000000000001196
. (2020). Incretin-based drugs and risk of lung cancer among individuals with type 2 diabetes. Diabet Med. http://doi.org/10.1111/dme.14287
. (2020). Cardiotoxicity of Sequential Aromatase Inhibitors Use in Women with Breast Cancer. Am J Epidemiol. http://doi.org/10.1093/aje/kwaa065
. (2020). Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study. Circulation. http://doi.org/10.1161/circulationaha.119.044750
.